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Peter A Ward* and Jamison J GrailerAbstract
Acute respiratory distress syndrome (ARDS) in humans involves ≥ 200,000 individuals in the United States, and has a
mortality rate (40%) for which no specific drug has been approved for use in humans. We have studied
experimental acute lung injury (ALI) in mice following airway deposition of bacterial lipopolysaccharide (LPS) or the
recombinant mouse complement anaphylatoxin, C5a. As ALI developed over 6 hr, extracellular histones appeared in
bronchoalveolar lavage fluids (BALF). Extracellular histone appearance required both C5a receptors (C5aR, C5L2) as
well as neutrophils (PMNs) and lung macrophages, as genetic loss of either C5a receptor or depletion of PMNs or
macrophages reduced histone levels found in BALF during ALI. It is possible that extracellular histones were derived
from formation of neutrophil extracellular traps (NETs) in lung after PMN contact with C5a. When purified histones
were delivered to lung via the airways, intense inflammatory injury ensued and type II cells developed large blebs
indicating cellular damage and apoptosis. Detailed physiological measurements revealed severe disruption of
blood/alveolar gas exchange. These data suggest a key role for histones in development of experimental ALI.
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Extracellular histones have recently been recognized as
appearing in plasma after endotoxemia or septic shock
in rodents and in non-human primates with septic shock
following infusion of live E. Coli bacteria [1]. In mice, in-
fusion of a histone mixture (purified from calf thymus)
led to rapid death which was likely linked to histone
binding to vascular endothelial cells resulting in endothe-
lial cell apoptosis [1]. Histones have also been implicated
in experimental acute liver injury (ischemia/reperfusion)
and experimental kidney injury (endotoxin-induced) [2,3].
In both cases, use of a neutralizing antibody to histones
was highly protective. In these examples of “sterile inflam-
mation”, there was evidence that Toll-like receptor (TLR)
2 and TLR4 were involved in the development of acute
kidney injury, and TLR9 was linked to liver injury, perhaps
functioning as receptors for histone binding to cells [2,3].
There is also evidence in human acute respiratory distress
syndrome (ARDS) that histones were present in broncho-
alveolar lavage fluids (BALF) [4]. Plasma histones have
recently been described in patients who developed
ARDS after non-penetrating polytrauma [5]. On a cellu-
lar level, extracellular histones are known to act as* Correspondence: pward@umich.edu
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reproduction in any medium, provided the origdamage-associated molecular patterns (DAMPs) that
can activate TLRs resulting in pro-inflammatory cytokine
production [2,3]. In addition, high levels of extracellular
histones are cytotoxic to endothelial and epithelial cells
[1,4,5], as well as several other cell types (JJG and PAW,
unpublished observations). The mechanism of the cyto-
toxic effects of extracellular histones is not entirely clear,
but appear to be due to their ability to interact with phos-
pholipids in the plasma membrane leading to increased
transmembrane conductance, calcium influx, cell swelling
and cytolysis [5,6]. In vivo, the cytotoxic effects of histones
may result in the further release of DAMPs leading to en-
hanced inflammation.
One possible source of histones is neutrophils (PMNs)
that both in vitro and in vivo can react with C5a to form
neutrophil extracellular traps (NETs) composed of DNA
and histones, as well as products from PMN granules
such as myeloperoxidase, which collectively trap bac-
teria, leading to their killing [7-9]. In the following re-
port, we will review our evidence in experimental acute
lung injury (ALI) that histones appear in BALF in a
complement and C5a receptor-dependent manner. Evi-
dence will be provided to directly link histone presence
with development of ALI.is is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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Induction of ALI and requirements for C5a receptors and
PMNs
All rodent procedures were performed within the U.S.
National Institutes of Health guidelines and were ap-
proved by the University of Michigan Committee on the
Use and Care of Animals. Airway instillation of 1 μg LPS
or C5a into mouse lung produced an accumulation of
mouse albumin in BALF, assessed by ELISA, that was
nearly 10 fold greater than in negative control lungs
from mice given sterile saline intratracheally (i.t.) [4].
Albumin leakage into lung is the result of both non-
specific epithelial/endothelial damage as well as active
modification of tight junctions [10,11]. As would be ex-
pected, large accumulations of PMNs in BALF occurred
in the positive controls (3–5 × 106). When C5a receptor
knockout mice were used (C5aR−/−, C5L2−/−), there was
greatly reduced albumin leak into lung (75-90%) and
PMN counts in BALF were very much reduced (60-80%).
A key accompanying finding was that in either C5aR−/− or
C5L2−/− mice, histone levels were reduced ≥ 90%, based
on ELISA, indicating that histone appearance was C5a
receptor-dependent. It was also demonstrated in wild type












Figure 1 Mechanisms of histone-induced ALI.specific epitope) antibody that there was a 70% reduction
of histones in BALF.
Requirements for histones in development of ALI
In the C5a model of ALI, a neutralizing mAb to H4 his-
tone was employed in mice. 250 μg was given i.v. and
50 μg i.t., resulting in the leak of albumin being reduced
by nearly 50% in BALF, and there was a broad reduction
in BALF levels of proinflammatory cytokines and che-
mokines [4]. These data indicated that histones play an
important role in development of the leak of albumin
into lung as well as the appearance of a broad spectrum
of proinflammatory cytokines and chemokines in BALF.
Ability of preformed histones to cause acute injury
to lung
A mixture of histones (20 μg/gm body weight) was injected
i.t. into Wt mouse lungs, resulting in lung consolidation
(as defined by high resolution MRI), consistent with in-
tense accumulation of water and PMNs [4]. Hematoxylin
and eosin staining of paraffin-embedded lung tissue re-
vealed intense alveolar edema and buildup of PMNs,
together with sloughing of airway epithelial cells and devel-
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dicating cell damage and/or apotosis. Functional measure-
ments showed arterial acidosis, elevations in arterial pCO2,
and arterial pO2 desaturation, together with a greatly amp-
lified respiratory rate, increased minute ventilation time
and a greatly reduced total respiratory cycle. All of this in-
dicates severe functional disturbances in lungs of mice re-
ceiving histones via the airways.
The source of extracellular histones during ALI
The cellular source of extracellular histones remains un-
clear. Histones are reported to be released from apop-
totic/necrotic cells in vitro [3,12]. Therefore, histones
may be released by damaged cells during ALI. In addition
to this possibility, histones are known to be associated
with neutrophil extracellular traps (NETs) [13]. NETs are
structures composed of DNA, histones, and granular pro-
teins (e.g., elastase, myeloperoxidase) released by neutro-
phils in response to a variety of agonists. NET release has
been demonstrated during experimental ALI [9]. There-
fore, histones in the extracellular space may be from dead/
dying cells, from neutrophils, or from both sources. Fur-
ther investigation is needed to clarify the source of extra-
cellular histones during ALI.
Evidence for extracellular histones during ARDS
The presence of extracellular histones in BALF from pa-
tients with ARDS was confirmed by both Western blot
and ELISA technology. Extracellular histones were de-
tected in 50% of patient BALFs from 0–10 days after ini-
tial diagnosis (n = 28). Lower rates of histone presence
was observed in BALF samples collected >10 days after
diagnosis (n = 24). There were no detectable histones in
BALFs from healthy control samples (n = 12). In serial
samples from single patients (e.g., collected 5, 14, and
21 days after initial diagnosis), histone presence was sus-
tained in some (observed in BALF samples from mul-
tiple days). In other patients, histones were only present
in early samples. Information about the patient sampling
for this study is described elsewhere [14]. The original
human study was approved by the Institutional Review
Board of the University of Michigan Health System.
Conclusions
Figure 1 outlines our current thoughts on the develop-
ment of ALI following airway deposition of C5a or LPS.
In each case, both C5a receptors were vital to develop-
ment of lung injury. Absence of either C5aR or C5L2
greatly attenuated ALI as quantitated by leak of albumin
into lung, buildup of PMNs and appearance of proin-
flammatory cytokines and chemokines in BALF. It has
already been shown by others that PMN contact with
C5a can cause NET formation [8,9], with the appearance
of histones and other bactericidal products from granulesof PMNs. There may well be other cell sources of histones
in the lung. Extracellular histones, once formed, had in-
tense lung damaging effects that markedly interfered with
air gas exchange between the capillary and alveolar com-
partments. Accordingly, it is possible in ARDS that his-
tones may represent a target for blockade. One such
candidate, activated protein C (APC), has been shown to
hydrolyze histones [1]. Inhaled APC was beneficial during
rodent and sheep experimental ALI [15,16]. However, a
phase II clinical trial which administered APC i.v. in pa-
tients with ARDS showed no improvement in outcome
[17]. The efficacy of inhaled APC has not been determined
in humans with ARDS, but might represent a promising
therapy [18]. Another potential therapeutic for ARDS may
be the development of humanized blocking/neutralizing
antibodies for histones.
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